PubRank

Robert N Doughty

Author PubWeight™ 52.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008 5.14
2 A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis. Am Heart J 2008 2.04
3 The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. Eur J Heart Fail 2009 1.63
4 Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure. J Am Coll Cardiol 2002 1.55
5 Serial Doppler echocardiography and tissue Doppler imaging in the detection of elevated directly measured left atrial pressure in ambulant subjects with chronic heart failure. JACC Cardiovasc Imaging 2011 1.54
6 Association of fat-free mass and training status with left ventricular size and mass in endurance-trained athletes. J Am Coll Cardiol 2004 1.48
7 National variability in provision of health services for major long-term conditions in New Zealand (a report from the ABCC NZ study). N Z Med J 2011 1.45
8 Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device. Circulation 2007 1.43
9 Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol 2003 1.25
10 Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC). Eur J Heart Fail 2012 1.21
11 Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from the Renal Hypertension Ablation System (RHAS) trial. EuroIntervention 2013 1.20
12 Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction. Am J Cardiol 2004 1.18
13 Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula. Circ Heart Fail 2012 1.11
14 Effect of six months' exercise training on C-reactive protein levels in healthy elderly subjects. J Am Coll Cardiol 2004 1.10
15 Age-related changes in myocardial relaxation using three-dimensional tagged magnetic resonance imaging. J Cardiovasc Magn Reson 2003 1.05
16 Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure). Eur J Heart Fail 2009 1.05
17 Regeneration of the heart in diabetes by selective copper chelation. Diabetes 2004 1.04
18 Understanding changing patterns of survival and hospitalization for heart failure over two decades in New Zealand: utility of 'days alive and out of hospital' from epidemiological data. Eur J Heart Fail 2010 1.00
19 Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J 2010 0.98
20 Structural and functional cardiac abnormalities in adolescent girls with poorly controlled type 2 diabetes. Diabetes Care 2009 0.97
21 Development and initial validation of a simple clinical decision tool to predict the presence of heart failure in primary care: the MICE (Male, Infarction, Crepitations, Edema) rule. Eur J Heart Fail 2012 0.94
22 Left ventricular diastolic filling and systolic function of young and older trained and untrained men. J Appl Physiol (1985) 2003 0.93
23 Redefining normal reference ranges for echocardiography: a major new individual person data meta-analysis. Eur Heart J Cardiovasc Imaging 2012 0.93
24 Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]). Am J Cardiol 2009 0.93
25 Progression of myocardial remodeling and mechanical dysfunction in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2012 0.92
26 Reduced exercise arteriovenous O2 difference in Type 2 diabetes. J Appl Physiol (1985) 2002 0.91
27 Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail 2012 0.90
28 The Singapore Heart Failure Outcomes and Phenotypes (SHOP) study and Prospective Evaluation of Outcome in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction (PEOPLE) study: rationale and design. J Card Fail 2013 0.89
29 Using mobile technology to support lower-salt food choices for people with cardiovascular disease: protocol for the SaltSwitch randomized controlled trial. BMC Public Health 2014 0.87
30 Effect of early initiation of dialysis on cardiac structure and function: results from the echo substudy of the IDEAL trial. Am J Kidney Dis 2012 0.87
31 Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report. Eur J Heart Fail 2013 0.86
32 Plasma urocortin 1 in human heart failure. Circ Heart Fail 2009 0.86
33 The effect of type 2 diabetes on diastolic function. Med Sci Sports Exerc 2006 0.85
34 Restrictive filling pattern is a powerful predictor of heart failure events postacute myocardial infarction and in established heart failure: a literature-based meta-analysis. J Card Fail 2007 0.82
35 Pseudonormal mitral filling is associated with similarly poor prognosis as restrictive filling in patients with heart failure and coronary heart disease: a systematic review and meta-analysis of prospective studies. J Am Soc Echocardiogr 2009 0.82
36 The prognostic significance of restrictive diastolic filling associated with heart failure: a meta-analysis. Int J Cardiol 2006 0.81
37 Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial. BMJ Open 2013 0.81
38 Intrapericardial IGF-I improves cardiac function in an ovine model of chronic heart failure. Heart Lung Circ 2005 0.81
39 Role of echocardiography in the contemporary management of chronic heart failure. Expert Rev Cardiovasc Ther 2005 0.80
40 The effect of an integrated care approach for heart failure on general practice. Fam Pract 2003 0.78
41 Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 diabetes mellitus. Expert Rev Cardiovasc Ther 2008 0.78
42 Does rhythm matter? The prognostic importance of atrial fibrillation in heart failure. Heart Lung Circ 2006 0.78
43 Quantitative evaluation of regional endocardial visualisation with second harmonic imaging and contrast left ventricular opacification in heart failure patients. Eur J Echocardiogr 2005 0.78
44 Comparison of different methods for detection of diastolic filling abnormalities. J Am Soc Echocardiogr 2005 0.77
45 The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics. Clin Res Cardiol 2009 0.77
46 Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community. Eur Heart J 2008 0.77
47 Individual patient meta-analyses of restrictive diastolic filling pattern and mortality in patients post acute myocardial infarction and in patients with chronic heart failure. Int J Cardiol 2007 0.77
48 Amino-terminal pro-C-type natriuretic peptide in heart failure. Hypertension 2003 0.77
49 Understanding differences in results from literature-based and individual patient meta-analyses: an example from meta-analyses of observational data. Int J Cardiol 2009 0.76
50 The relationship between BNP and E/Ea in patients hospitalized with acute heart failure. Int J Cardiol 2007 0.75
51 Mechanisms of benefit of sustained weight reduction in morbid obesity: beyond reduction in conventional cardiovascular risk factors. J Hypertens 2007 0.75
52 Definition of physiological hypertrophy in ultramarathon athletes. J Am Coll Cardiol 2004 0.75
53 A continued role for beta-blocker therapy in heart failure. Heart Fail Monit 2006 0.75
54 Which cardiovascular risk factors are associated with cardiovascular disease and predict future events in advanced age in New Zealand? Australas J Ageing 2012 0.75
55 Brain natriuretic peptide in the contemporary management of congestive heart failure. Expert Rev Cardiovasc Ther 2005 0.75
56 Prediction of ACC/AHA Stage B heart failure by clinical and neurohormonal profiling among patients in the community. J Card Fail 2010 0.75
57 A comparison of the effects of indexation on standard echocardiographic measurements of the left heart in a healthy multi-racial population. Int J Cardiovasc Imaging 2014 0.75
58 Changes in tissue-Doppler echocardiographic assessment of left ventricular filling during NT-proBNP guided heart failure treatment titration: a pilot study. Heart Lung Circ 2008 0.75
59 Effect of tissue harmonic imaging and contrast upon between observer and test-retest reproducibility of left ventricular ejection fraction measurement in patients with heart failure. Eur J Heart Fail 2004 0.75
60 Prognostic implications of left ventricular dilation in patients with nonischemic heart failure: interactions with restrictive filling pattern and mitral regurgitation. Congest Heart Fail 2012 0.75
61 Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure. Clin Cardiol 2009 0.75